Elder Pharmaceuticals Ltd Nine Monthly Results

Gross Sales

508.5

883.29

1,131.54

973.85

656.48

Excise Duty

0

0

0

0

0

Net Sales

508.5

883.29

1,131.54

973.85

656.48

Other Operating Income

4.63

5.38

1.94

1.09

0.62

Other Income

16.43

25.95

18.34

6.9

5.09

Total Income

529.54

914.64

1,151.81

981.84

662.21

Total Expenditure

580.82

819.71

963.25

817.42

536.7

PBIDT

-51.27

94.93

188.57

164.41

125.51

Interest

90.69

155.61

84.43

63

46.68

PBDT

-141.94

-60.68

104.13

101.41

78.83

Depreciation

30.67

29.81

26.97

27.82

20.54

Minority Interest Before NP

0

0

0

0

0

Tax

3.52

3.3

16.84

16.14

13

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-176.14

-93.81

60.31

57.43

45.29

Minority Interest After NP

0

0

0

-0.31

-0.88

Net Profit after Minority Interest

-176.14

-93.81

60.31

57.75

46.18

Extra-ordinary Items

5.01

2.32

-4

-3.06

-3.28

Adjusted Profit After Extra-ordinary item

-181.15

-96.14

64.31

60.81

49.47

EPS (Unit Curr.)

-85.76

-45.68

29.37

28.12

22.48

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

20.54

20.54

20.54

20.54

20.54

Public Shareholding (Number)

1,53,54,553

1,54,36,656

1,23,43,803

1,24,04,803

1,28,21,128

Public Shareholding (%)

74.76

75.16

60.09

60.4

62.43

Pledged/Encumbered - No. of Shares

44,08,131

46,66,131

67,29,802

47,19,650

51,21,570

Pledged/Encumbered - % in Total Promoters Holding

85.05

91.48

82.13

58.04

66.37

Pledged/Encumbered - % in Total Equity

21.45

22.71

32.77

22.97

24.94

Non Encumbered - No. of Shares

7,74,251

4,34,149

14,63,331

34,12,483

25,94,238

Non Encumbered - % in Total Promoters Holding

14.93

8.51

17.86

41.95

33.63

Non Encumbered - % in Total Equity

3.76

2.1

7.13

16.62

12.61

PBIDTM(%)

-10.08

10.74

16.66

16.88

19.11

PBDTM(%)

-27.91

-6.87

9.2

10.41

12

PATM(%)

-34.64

-10.62

5.33

5.89

6.9